CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Development of a vector based on natural excipient in order to reduce the therapeutic doses of current treatments and their adverse effects in chronic inflammatory bowel diseases (IBD).
Authors
Delanne Améline
Eric Beyssac
+6 more
Frédéric Antonio Carvalho
arthur chevet
Jérémy Denizot
Laine Emmanuelle
Khaled Fadhlaoui
Ghislain Garrait
Publication date
17 June 2021
Publisher
HAL CCSD
Abstract
International audienc
Similar works
Full text
Available Versions
HAL Clermont Université
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:HAL:hal-03417146v1
Last time updated on 26/12/2021